These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Inhibition of bradycardia pacing and detection of ventricular fibrillation due to far-field atrial sensing in a triple chamber implantable cardioverter defibrillator. Vollmann D; Lüthje L; Görtler G; Unterberg C Pacing Clin Electrophysiol; 2002 Oct; 25(10):1513-6. PubMed ID: 12418750 [TBL] [Abstract][Full Text] [Related]
27. Initial experience with a new balloon-guided single lead catheter for internal cardioversion of atrial fibrillation and dual chamber pacing. Plewan A; Valina C; Herrmann R; Alt E Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 2):228-32. PubMed ID: 9990636 [TBL] [Abstract][Full Text] [Related]
29. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials. Wilkoff BL; Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277 [TBL] [Abstract][Full Text] [Related]
30. Atrial fibrillation reduces the atrial impedance amplitude during cardiac cycle: a novel detection algorithm to improve recognition of atrial fibrillation in pacemaker patients. Schmidt B; Asbach S; Schweika O; Zehender M; Bode C; Faber TS Europace; 2007 Sep; 9(9):812-6. PubMed ID: 17545214 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of atrial antitachycardia functions for treating atrial fibrillation: observations in patients with a dual-chamber defibrillator. Ricci R; Pignalberi C; Santini M Card Electrophysiol Rev; 2003 Dec; 7(4):348-51. PubMed ID: 15071251 [TBL] [Abstract][Full Text] [Related]
32. The results of pacing trials for the prevention and termination of atrial tachyarrhythmias: is there any evidence of therapeutic breakthrough? Savelieva I; Camm AJ J Interv Card Electrophysiol; 2003 Apr; 8(2):103-15. PubMed ID: 12766501 [TBL] [Abstract][Full Text] [Related]
33. [Cardiac remodelling and function after cardiovascular implantable electronic devices implantation]. Stanek A; Lelakowski J; Matusik PT Pol Merkur Lekarski; 2019 Apr; 46(274):187-189. PubMed ID: 31099767 [TBL] [Abstract][Full Text] [Related]
35. First worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator. Advantages and complications. The Ventak AV II DR investigators. Sticherling C; Schaumann A; Klingenheben T; Hohnloser SH Europace; 1999 Apr; 1(2):96-102. PubMed ID: 11233190 [TBL] [Abstract][Full Text] [Related]
36. Proarrhythmic effect of automatic threshold testing algorithm in dual chamber devices. Larsen TR; Sargent D; Moyes M; Huizar JF; Tan AY; Ellenbogen KA; Kaszala K J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2078-2085. PubMed ID: 32510718 [TBL] [Abstract][Full Text] [Related]
37. His-bundle pacing using dual-chamber cardioverter-defibrillator in patients with chronic atrial fibrillation: different pacing and sensing features. Sławuta A; Biały D; Zyśko D; Mazur G; Gajek J Acta Cardiol; 2017 Jun; 72(3):343-344. PubMed ID: 28636524 [No Abstract] [Full Text] [Related]
38. Technological Advances in Arrhythmia Management Applied to Adults With Congenital Heart Disease. Mondésert B; Nair K; McLeod CJ; Khairy P Can J Cardiol; 2019 Dec; 35(12):1708-1722. PubMed ID: 31813504 [TBL] [Abstract][Full Text] [Related]